After closing a $40 million Series B, Micropep now looks to bring its crop protection products based on micropeptides to market.
St. Louis-based Peptyde Bio hopes to strengthen the power of bio-fungicides with its platform that designs and discovers anti-microbial peptides.
The French startup is aiming to have its first biofungicide product on the market within the next three years.
“We have additional insecticide candidates at earlier stages in our pipeline, as well as our first fungicidal candidates,” CEO Anna Rath tells AFN.
The Series B funds will be used to scale up the Irish company’s platform, which aims to unlock additional health benefits for food and beverage products.
The Toulouse-based startup has developed technology that can enhance favorable genetic traits in crops without the need to tinker with their DNA.
Bovine mastitis is a major financial and welfare problem for dairy farmers, but standard antibiotic treatments are increasingly controversial.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first